The characterization and biodistribution of cefoxitin-loaded liposomes

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 31-39

  Wu, Pao Chu ^a   Tsai, Yi Hung ^a   Liao, Chung Cheng ^a   Chang, Jui Sheng ^a   Huang, Yaw Bin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biodistribution; Cefoxitin; Liposome; Stability

Indexed keywords

CEFOXITIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RETENTION; DRUG STABILITY; DRUG STORAGE; DRUG TISSUE LEVEL; ENCAPSULATION; EVAPORATION; IN VIVO STUDY; LIVER; MALE; NONHUMAN; PANCREAS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SPLEEN;

EID: 1142309797     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.10.034     Document Type: Article

References (18)

1. Betageri G.V. Liposomal encapsulation and stability of dideoxyinosine triphosphate. Drug Dev. Ind. Pharm. 19:1993;531-539.
2. Dean T.P., Hider R.C. Incorporation of alphaxalone into different types of liposomes. J. Pharm. Pharmacol. 45:1993;990-992.
3. Fang J.Y., Lin H.H., Hsu L.R., Tsai Y.H. Characterization and stability of various liposome-encapsulated enoxacin formulations. Chem. Pharm. Bull. 45:1997;1504-1509.
4. Fielding R.M. Liposomal drug delivery: advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clin. Pharmacokinet. 21:1991;155-164.
5. Hirano K., Hunt C.A. Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. J. Pharm. Sci. 74:1985;915-921.
6. Kiwada H., Nakajima I., Matsuura M., Tsuji M., Kato Y. Application of synthetic alkyl glycoside vesicles as drug carriers. III. Plasma components affecting stability of the vesicles. Chem. Pharm. Bull. 36:1988;1841-1846.
7. Kresta A., Shek P.N., Odumeru J., Bohnen J.M. Distribution of free and liposome- encapsulated cefoxitin in experimental intra-abdominal sepsis in rats. J. Pharm. Pharmacol. 45:1993;779-783.
8. Lau W.L., Fan S.T., Chu K.W., Yip W.C., Yiu T.F., Yeung C., Wang K.K. Cefoxitin versus gentamicin and metronidazole in prevention of post-appendiectomy sepsis: a randomized prospective trial. J. Antimicrob. Chemoth. 18:1986;613-619.
9. Lefrock J., Blais L., Shell R.F. Cefoxitin in the treatment of diabetic patients with lower extremity infections. Infect. Surg. 2:1983;361-374.
10. Lin H.H., Ko S.M., Hsu L.R., Tsai Y.H. The preparation of norfloxacin-loaded liposomes and its in vitro evaluation in pig's eye. J. Pharm. Pharmacol. 48:1996;801-805.
11. Price C.I., Horton J.W., Baxter C.R. Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier. Arch. Surg. 124:1989;1411-1415.
12. Sanchez P.L., Wingall F.S., Zajdouicz T.R., Krebs S., Berg S.W., Harrison W.O. One gram of cefoxitin cures uncomplicated gonococcal urethritis cause by penicillinase-producing Neisseria gonorrhea (PPNG). Sex Transm. Dis. 10:1983;135-137.
13. Sharma A., Sharma U.S. Liposome in drug delivery: progress and limitations. Int. J. Pharm. 154:1997;123-140.
14. Siler-Marinkovic S., Mojovic L., Davinic V., Bugarski B. Liposomes as carriers of antimicrobial drugs. Drug Dev. Ind. Pharm. 23:1997;483-488.
15. Sweet R.L., Schachter J., Landers D.V. Treatment of hospitalized patient with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am. J. Obstet. Gynecol. 158:1988;736-743.
16. Tally F.P. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann. Surg. 293:1981;318-323.
17. Taylor K.M.G., Taylor G., Kellaway I.W., Steven J. Drug entrapment and release from multilamellar and reverse phase evaporation liposomes. Int. J. Pharm. 58:1990;49-55.
18. Yu H.Y., Liao H.M. Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int. J. Pharm. 127:1996;1-7.